Breaking the Ice: Early Clinical Results Using Hypothermic Machine Liver Preservation

被引:0
作者
Klair T.S. [1 ]
Guarrera J.V. [1 ,2 ]
机构
[1] Center for Liver Disease and Transplantation, Department of Surgery, Columbia University Medical Center, New York, NY
[2] Center for Liver Disease and Transplantation, Columbia University College of Physicians and Surgeons, 622 West 168th Street PH 14C, Room 202, New York, 10032, NY
关键词
Extended criteria donor; Hypothermic machine preservation; Liver transplantation; Machine perfusion; Organ preservation; Transplant outcomes;
D O I
10.1007/s40472-014-0040-7
中图分类号
学科分类号
摘要
Hypothermic machine preservation (HMP) remains investigational in clinical liver transplantation. It is widely used, however, to preserve kidneys for transplantation because it has demonstrated improved results over static cold storage (CS). As with other machine preservations methods, HMP provides continuous circulation of nutrients and metabolic substrates during the ex-vivo period. Over the last few years, several groups worldwide have been actively translating HMP into the clinical arena for liver transplantation. In particular, HMP has been used for livers of varying quality, including those recovered from extended criteria donors (ECD) and donation after cardiac death (DCD) donors. Reports to date have focused on recipient hospital based HMP during the latter portion of the cold ischemic period. While some variability exists in technique, all clinical series to date have reported improved outcomes with reductions in early allograft dysfunction, biliary complications and reduced hospital length of stay. These benefits, together with the development of innovative portable HMP devices and further adoption by more centers worldwide, have “broken the ice” for more widespread use of HMP and subsequent expanded elucidation of its benefits. © 2015, Springer International Publishing AG.
引用
收藏
页码:63 / 67
页数:4
相关论文
共 18 条
[1]  
Thuluvath P.J., Guidinger M.K., Fung J.J., Johnson L.B., Rayhill S.C., Pelletier S.J., Liver transplantation in the United States, 1999-2008, Am J Transplant, 10, 4, pp. 1003-1019, (2010)
[2]  
Moers C., Smits J.M., Maathuis M.H., Treckmann J., van Gelder F., Napieralski B.P., Et al., Machine perfusion or cold storage in deceased-donor kidney transplantation, N Engl J Med, 360, 1, pp. 7-19, (2009)
[3]  
Schlegel A., Dutkowski P., Role of hypothermic machine perfusion in liver transplantation, Transplant Int, (2014)
[4]  
Van Golen R.F., van Gulik T.M., Heger M., Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury, Free Radic Biol Med, 52, (2012)
[5]  
Zhai Y., Petrowsky H., Hong J.C., Busuttil R.W., Kupiec-Weglinski J.W., Ischaemia-reperfusion injury in liver transplantation- from bench to bedside, Nat Rev Gastroenterol Hepatol, 10, (2013)
[6]  
Land W.G., Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells, Transplant Rev (Orlando), 26, (2012)
[7]  
Schlegel A., Rougemont O., Graf R., Clavien P.A., Dutkowski P., Protective mechanisms of end-ischemic cold machine perfusion in DCD liver grafts, J Hepatol, 58, pp. 278-286, (2013)
[8]  
Tulipan J.E., Stone J., Samstein B., Guarrera J.V., Et al., Expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum and liver biopsies, Surgery, 150, 2, pp. 352-360, (2011)
[9]  
Guarrera J.V., Henry S.D., Chen S.W., Brown T., Nachber E., Arrington B., Et al., Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results, J Surg Res, 167, 2, pp. e365-e373, (2011)
[10]  
Henry S.D., Nachber E., Tulipan J., Stone J., Bae C., Reznik L., Et al., Hypothermic machine preservation reduces molecular markers of ischemia/ reperfusion injury in human liver transplantation, Am J Transplant, 12, 9, pp. 2477-2486, (2012)